Who owns Armata Pharmaceuticals Inc?
- Ticker: ARMP
- CUSIP Number: 04216r102
Tip: Access positions for across all investors
Analyze quarterly positions in Armata Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Armata Pharmaceuticals stock
Who bought or sold Armata Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 358k | $2.2M | 20% | Dec 2025 |
|
| 683 Capital Management | 140k | $878k | 100% | Dec 2025 |
|
| Geode Capital Management | 110k | $690k | 5% | Dec 2025 |
|
| Edgewood Management | 100k | $628k | 0% | Dec 2025 |
|
| Renaissance Technologies | 69k | $430k | 66% | Dec 2025 |
|
| State Street Corporation | 51k | $319k | 26% | Dec 2025 |
|
| Goldman Sachs Group | 45k | $284k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 45k | $133k | 0% | Sep 2025 |
|
| SeaCrest Wealth Management | 41k | $274k | 17% | Dec 2025 |
|
| GSB Wealth Management | 30k | $188k | 0% | Dec 2025 |
|
| OMERS Administration Corporation | 28k | $177k | 100% | Dec 2025 |
|
| BlackRock | 27k | $80k | 3% | Sep 2025 |
|
| Northern Trust | 25k | $155k | 28% | Dec 2025 |
|
| Susquehanna International | 24k | $153k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 23k | $147k | 100% | Dec 2025 |
|
| Jane Street | 17k | $108k | 100% | Dec 2025 |
|
| Captrust Financial Advisors | 13k | $39k | 0% | Sep 2025 |
|
| Tower Research Capital | 1.6k | $10k | 352% | Dec 2025 |
|
| Cornerstone National Bank & Trust | 1.4k | $9.0k | 0% | Dec 2025 |
|
| UBS Group | 1.0k | $6.4k | 2220% | Dec 2025 |
|
| Measured Wealth Private Client Group | 1.0k | $6.3k | 0% | Dec 2025 |
|
| Trifecta Capital Advisors | 714.00 | $4.5k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 710.00 | $4.5k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 571.00 | $3.6k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 357.00 | $2.2k | -22% | Dec 2025 |
|
| Whittier Trust | 100.00 | $587.000000 | 100% | Dec 2025 |
|
| Geneos Wealth Management | 92.00 | $577.999200 | 100% | Dec 2025 |
|
| MAI Wealth Advisors | 71.00 | $446.000700 | 0% | Dec 2025 |
|
| Team Financial Group | 71.00 | $446.000700 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 24.00 | $72.000000 | 100% | Sep 2025 |
|
| SBI Securities | 3.00 | $9.000000 | 0% | Sep 2025 |
|
| Wells Fargo & Company | 1.00 | $3.000000 | 0% | Dec 2025 |
|
Who sold out of Armata Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Group One Trading | Sep 2025 | 3.0k | $8.9k |
| Raymond James Financial | Jun 2025 | 1.0k | $1.9k |
| Salem Investment Counselors | Sep 2025 | 100.00 | $298.000000 |
| Barclays | Sep 2025 | 6.00 | $18.000000 |